# EDGAR Filing Document

**Accession Number:** 0000816956
**File Stem:** 0000816956-26-000063
**Filing Date:** 2026-6
**Character Count:** 7719
**Document Hash:** ed31c87b166e83e3e5270c961d167aef
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0000816956-26-000063.hdr.sgml**: 20260603

**ACCESSION NUMBER**: 0000816956-26-000063

**CONFORMED SUBMISSION TYPE**: 3/A

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260601

**FILED AS OF DATE**: 20260603

**DATE AS OF CHANGE**: 20260603

**REPORTING-OWNER**: 

**OWNER DATA:**
- **COMPANY CONFORMED NAME:** Lockwood Kimberly
- **CENTRAL INDEX KEY:** 0002136158

**ORGANIZATION NAME:**

**FILING VALUES:**
- **FORM TYPE:** 3/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 001-39218
- **FILM NUMBER:** 261059749

**MAIL ADDRESS:**
- **STREET 1:** 11311 CONCEPT BLVD
- **CITY:** LARGO
- **STATE:** FL
- **ZIP:** 33773
**ISSUER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** CONMED Corp
- **CENTRAL INDEX KEY:** 0000816956
- **STANDARD INDUSTRIAL CLASSIFICATION:** ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845]
- **ORGANIZATION NAME:** 08 Industrial Applications and Services
- **EIN:** 160977505
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**BUSINESS ADDRESS:**
- **STREET 1:** 11311 CONCEPT BOULEVARD
- **CITY:** LARGO
- **STATE:** FL
- **ZIP:** 33773
- **BUSINESS PHONE:** 727-214-2974

**MAIL ADDRESS:**
- **STREET 1:** 11311 CONCEPT BOULEVARD
- **CITY:** LARGO
- **STATE:** FL
- **ZIP:** 33773

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** CONMED CORP
- **DATE OF NAME CHANGE:** 19920703

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## FORM 3/A

### STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

[ ] Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

---

| | | |
|:---|:---|:---|
| **1. Name and Address of Reporting Person**<sup>*</sup><br>Lockwood Kimberly<br><sub>(Last) (First) (Middle)</sub><br>C/O CONMED CORPORATION<br>11311 CONCEPT BOULEVARD<br><sub>(Street)</sub><br>LARGO, FL 33773<br><sub>(City) (State) (Zip)</sub> | **3. Date of Earliest Transaction (Month/Day/Year)**<br>2026-06-01 | **5. Relationship of Reporting Person(s) to Issuer**<br>(Check all applicable)<br>[ ] Director [ ] 10% Owner<br>[X] Officer (give title below) [ ] Other (specify below)<br>_Interim Corp Controller & PAO_ |
| **2. Issuer Name and Ticker or Trading Symbol**<br>CONMED Corp [ CNMD ] | **4. If Amendment, Date of Original Filed (Month/Day/Year)**<br>  | **6. Individual or Joint/Group Filing (Check Applicable Line)**<br>[X] Form filed by One Reporting Person<br>[ ] Form filed by More than One Reporting Person |

---

## Table I - Non-Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | 3. Transaction Code (V) | 3. Transaction Code (V) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 4. Securities Acquired (A) or Disposed of (D) | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| 1. Title of Security | 2. Transaction Date | 2A. Deemed Execution Date | Code | V | Amount | (A) or (D) | Price | 5. Amount of Securities Beneficially Owned | 6. Ownership Form | 7. Nature of Indirect Beneficial Ownership |
| Common Stock |  |  |  |  |  |  |  | 1868 | D |  |

---

## Table II - Derivative Securities

---

|  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | 4. Transaction Code (V) | 4. Transaction Code (V) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 5. Number of Derivative Securities Acquired (A) or Disposed of (D) | 6. Date Exercisable and Expiration Date | 6. Date Exercisable and Expiration Date | 7. Title and Amount of Underlying Securities | 7. Title and Amount of Underlying Securities | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| 1. Title of Derivative Security | 2. Conversion or Exercise Price | 3. Transaction Date | 3A. Deemed Execution Date | Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | 8. Price of Derivative Security | 9. Number of Derivative Securities Beneficially Owned | 10. Ownership Form | 11. Nature of Indirect Beneficial Ownership |
| Options To Purchase Common Stock | $59.96 |  |  |  |  |  |  | <sup>(1)</sup> | 2028-03-01 | Common Stock | 1400 |  |  | D |  |
| Options To Purchase Common Stock | $78.76 |  |  |  |  |  |  | <sup>(2)</sup> | 2029-03-01 | Common Stock | 3200 |  |  | D |  |
| Options To Purchase Common Stock | $97.69 |  |  |  |  |  |  | <sup>(2)</sup> | 2030-03-02 | Common Stock | 3500 |  |  | D |  |
| Options To Purchase Common Stock | $122.55 |  |  |  |  |  |  | <sup>(2)</sup> | 2031-03-01 | Common Stock | 3500 |  |  | D |  |
| Options To Purchase Common Stock | $144.55 |  |  |  |  |  |  | <sup>(2)</sup> | 2032-03-01 | Common Stock | 2750 |  |  | D |  |
| Options To Purchase Common Stock | $96.16 |  |  |  |  |  |  | <sup>(2)</sup> | 2033-03-01 | Common Stock | 2500 |  |  | D |  |
| Options To Purchase Common Stock | $79.95 |  |  |  |  |  |  | <sup>(2)</sup> | 2034-03-01 | Common Stock | 2500 |  |  | D |  |
| Options To Purchase Common Stock | $58.33 |  |  |  |  |  |  | <sup>(2)</sup> | 2035-03-03 | Common Stock | 4500 |  |  | D |  |
| RSUs (Restricted Stock Units) | $0 |  |  |  |  |  |  | <sup>(3)</sup> | 2036-03-02 | Common Stock | 2839 |  |  | D |  |
| RSUs (Restricted Stock Units) | $0 |  |  |  |  |  |  | <sup>(3)</sup> | 2036-05-11 | Common Stock | 2838 |  |  | D |  |

---

### Footnotes:

(1) The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

(2) The stock options were granted under the Company's 2018 Long-Term Incentive Plan and generally vest in equal amounts over a five year period.

(3) Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of CONMED Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2025 Long-Term Incentive Plan, with the RSUs generally vesting over a three-year period with the first 33% of the RSUs vesting one year after the grant date, 33% second year and 34% third year.

**Remarks:**
This Form 3/A is filed solely to correct the officer title which was incorrect in the initial filing.

**Signature:** /s/ Thomas Fistek for Kimberly Lockwood by Power of Attorney  
**Date:** 2026-06-03

### Remarks:

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.

* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).

** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

**Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.**